SREBF2 and hyperlipidemia: In this study, the expression of SREBP-2 and its target genes HMGCR was significantly increased in the liver of mice with hyperlipidemia induced by HFD and the administration of SCL could decrease the expression of key factors of cholesterol synthesis, reduce the cholesterol synthesis and alleviate the toxicity of cholesterol in the mice.